# Cardamom Seeds (Elettaria cardamomum)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/cardamom-seeds
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-31
**Evidence Score:** 2 / 10
**Category:** Seed Oils
**Also Known As:** Elettaria cardamomum, Green cardamom seeds, True cardamom seeds, Lesser cardamom seeds, Malabar cardamom, Choti elaichi seeds, Elachi seeds, Cardamomo seeds, Queen of spices seeds

## Overview

Cardamom seeds (Elettaria cardamomum) contain bioactive volatile oils — primarily 1,8-cineole and α-terpinyl acetate — along with polyphenols that modulate insulin signaling, [inflammatory](/ingredients/condition/inflammation) cytokines, and vascular tone. These compounds interact with PPAR-γ receptors and [antioxidant](/ingredients/condition/antioxidant) pathways to produce documented metabolic and [cardiovascular](/ingredients/condition/heart-health) effects.

## Health Benefits

• May improve glycemic control in type 2 diabetes - one RCT showed significant reductions in HbA1c, insulin, and HOMA-IR with 3g/day for 10 weeks (moderate evidence)
• Potentially reduces [blood pressure](/ingredients/condition/heart-health) - one RCT found significant decreases in systolic and diastolic BP in stage 1 hypertension patients with 3g/day for 12 weeks (preliminary evidence)
• May improve lipid profiles - one RCT showed reduced total cholesterol (p=0.02) and LDL-C (p=0.01) with supplementation (preliminary evidence)
• Possibly reduces [inflammation](/ingredients/condition/inflammation) - systematic review found significant hs-CRP reduction in studies ≥10 weeks duration (preliminary evidence)
• May enhance [antiviral](/ingredients/condition/immune-support) immunity through type I interferon responses via STING-dependent pathways (in-vitro evidence only)

## Mechanism of Action

The volatile oil constituent 1,8-cineole and flavonoids in cardamom activate PPAR-γ receptors, enhancing [insulin sensitivity](/ingredients/condition/weight-management) and reducing HOMA-IR. Cardamom polyphenols inhibit NF-κB signaling, suppressing [pro-inflammatory cytokine](/ingredients/condition/inflammation)s such as TNF-α and IL-6, while also inhibiting ACE (angiotensin-converting enzyme) activity, contributing to vasodilation and [blood pressure](/ingredients/condition/heart-health) reduction. Additionally, α-terpinyl acetate and other terpenoids exhibit antioxidant activity by scavenging [reactive oxygen species](/ingredients/condition/antioxidant) and upregulating Nrf2-mediated antioxidant enzymes.

## Clinical Summary

A 10-week RCT in type 2 diabetes patients found that 3g/day of cardamom powder significantly reduced HbA1c, fasting insulin, and HOMA-IR compared to placebo, representing moderate-quality evidence. A separate RCT in stage 1 hypertension patients demonstrated significant reductions in both systolic and diastolic [blood pressure](/ingredients/condition/heart-health) following cardamom supplementation. Sample sizes in available trials are generally small (20–80 participants), and most studies are short-term, limiting the generalizability of findings. Overall, evidence is promising but preliminary; large-scale, long-duration RCTs are needed before firm clinical recommendations can be made.

## Nutritional Profile

Per 100g dried cardamom seeds: Calories ~311 kcal, Carbohydrates ~68g (of which dietary fiber ~28g, representing ~100% DV), Protein ~11g, Total Fat ~7g (predominantly unsaturated: oleic acid ~37% of fatty acids, linoleic acid ~32%, palmitic acid ~18%). Key micronutrients: Manganese ~28mg (1,217% DV - exceptionally high, primary mineral of note), Iron ~14mg (~78% DV), Zinc ~7.5mg (~68% DV), Magnesium ~229mg (~54% DV), Calcium ~383mg (~29% DV), Potassium ~1,119mg (~24% DV), Phosphorus ~178mg (~14% DV). Vitamins: Vitamin C ~21mg (~23% DV), Niacin (B3) ~1.1mg, Riboflavin (B2) ~0.18mg, Thiamine (B1) ~0.20mg. Primary bioactive compounds: Volatile essential oil constituents comprising 2–10% of seed weight, dominated by 1,8-cineole (eucalyptol, ~36–60% of essential oil), α-terpinyl acetate (~25–35%), linalool (~3–6%), α-terpineol (~3%), sabinene (~3%), and limonene (~2–3%). Non-volatile bioactives include flavonoids (quercetin, kaempferol glycosides), terpenoids, and phenolic acids including caffeic and protocatechuic acid at low concentrations (~50–200 mg/100g total phenolics). Fixed oil fraction contains phospholipids and plant sterols (β-sitosterol predominant). Bioavailability notes: Essential oil compounds are lipophilic and absorption is enhanced with dietary fat co-ingestion; grinding seeds significantly increases volatile oil bioavailability compared to whole seeds; the high fiber content may moderately reduce mineral absorption via phytate binding, though manganese and iron bioavailability from cardamom are considered moderate; 1,8-cineole is rapidly absorbed across gastrointestinal membranes and detectable in plasma within 15–30 minutes of ingestion.

## Dosage & Preparation

Clinically studied dose: 3 grams per day of green cardamom powder for 8-16 weeks. Supercritical CO2 extract studied only in animals at 550 mg/kg. No standardized extracts have been tested in humans. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Cardamom is generally recognized as safe (GRAS) at culinary doses, and supplemental doses up to 3g/day have been well tolerated in clinical trials with no serious adverse events reported. Because cardamom may lower [blood glucose](/ingredients/condition/weight-management) and [blood pressure](/ingredients/condition/heart-health), concurrent use with antidiabetic drugs (e.g., metformin, insulin) or antihypertensives (e.g., ACE inhibitors, calcium channel blockers) could produce additive effects requiring dose monitoring. Cardamom may inhibit CYP3A4 and CYP2C9 enzymes at high doses, potentially elevating plasma levels of drugs metabolized by these pathways, though robust human data are lacking. Pregnant and breastfeeding women should limit intake to culinary amounts, as high-dose supplementation safety has not been established in these populations.

## Scientific Research

Clinical evidence for cardamom is limited to small RCTs primarily in metabolic conditions, with mixed results. A systematic review (PMID: 36181264) of green cardamom in metabolic syndrome found potential benefits on [blood pressure](/ingredients/condition/heart-health) and [inflammation](/ingredients/condition/inflammation), though results were inconsistent. No large-scale RCTs or meta-analyses have been conducted, and most studies used 3g/day of whole cardamom powder for 8-16 weeks.

## Historical & Cultural Context

Cardamom has been used for over 1,000 years in Ayurvedic and Unani medicine systems for digestive issues, respiratory ailments, and as a carminative spice. Traditional Persian and Islamic medicine employed it for metabolic disorders, with historical use including [anti-inflammatory](/ingredients/condition/inflammation) and antihypertensive applications in herbal formulations.

## Synergistic Combinations

Cinnamon, Turmeric, Ginger, Fenugreek, Black Pepper

## Frequently Asked Questions

### How much cardamom should I take daily for blood sugar control?

The most cited RCT used 3g/day of cardamom powder for 10 weeks and observed significant reductions in HbA1c and fasting insulin in type 2 diabetes patients. This dose is well above typical culinary use, so supplemental capsule forms are generally required to reach it. Always consult a healthcare provider before supplementing, especially if you are on antidiabetic medications.

### Does cardamom lower blood pressure, and how long does it take?

At least one RCT in stage 1 hypertension patients demonstrated significant decreases in both systolic and diastolic blood pressure after cardamom supplementation over several weeks. The proposed mechanism involves ACE inhibition and vasodilatory effects of its volatile oil constituents, particularly 1,8-cineole. Results may begin to emerge within 4–8 weeks, though individual responses vary and evidence remains limited to small trials.

### What is the main active compound in cardamom seeds?

The primary bioactive compounds in cardamom seeds are volatile oils — chiefly 1,8-cineole (up to 35–40% of the essential oil) and α-terpinyl acetate — along with flavonoid polyphenols such as quercetin and kaempferol derivatives. 1,8-cineole is largely responsible for anti-inflammatory and ACE-inhibitory activity, while the polyphenols contribute to antioxidant and insulin-sensitizing effects via PPAR-γ activation. The composition can vary depending on geographic origin and processing method.

### Can cardamom interact with any medications?

Cardamom has demonstrated blood glucose-lowering and antihypertensive properties, so it may potentiate the effects of insulin, metformin, ACE inhibitors, or calcium channel blockers, increasing the risk of hypoglycemia or hypotension. There is also preliminary in vitro evidence that cardamom constituents may inhibit CYP3A4 and CYP2C9 enzymes, which could raise plasma concentrations of drugs like statins, warfarin, or certain antihistamines metabolized by these pathways. Human pharmacokinetic interaction data are currently insufficient, so caution and medical supervision are advised when combining high-dose cardamom supplements with prescription medications.

### Is cardamom safe during pregnancy?

Cardamom used as a culinary spice in normal food amounts is considered safe during pregnancy and is widely consumed in South Asian cuisines without documented harm. However, high-dose cardamom supplements (e.g., 3g/day or more) have not been evaluated in pregnant or breastfeeding populations in controlled trials, so safety at these levels cannot be confirmed. Pregnant women are advised to restrict cardamom intake to culinary quantities and consult their obstetrician before using any supplemental form.

### What is the most effective form of cardamom for supplements—whole seeds, powder, or extract?

Cardamom powder and whole seeds retain most active compounds, though powdered forms may offer better bioavailability due to increased surface area for absorption. Clinical studies showing benefits for blood sugar and blood pressure control have primarily used ground cardamom (3g/day), making this form the most evidence-supported option. Extracts are more concentrated but lack the research validation of whole or ground cardamom in human trials.

### Who benefits most from cardamom supplementation—are there specific health conditions where it's most effective?

Individuals with type 2 diabetes or stage 1 hypertension appear to benefit most from cardamom supplementation based on available clinical evidence, particularly at 3g daily doses. Those with borderline lipid profiles may also see improvements, though this requires more research confirmation. People with normal blood sugar, blood pressure, and cholesterol levels may experience minimal additional benefits from supplementation.

### How does the evidence quality for cardamom compare to other blood sugar and blood pressure supplements?

Cardamom has moderate evidence for blood sugar control (one RCT showing HbA1c reduction) and preliminary evidence for blood pressure reduction, placing it behind more extensively studied ingredients like cinnamon or berberine for glycemic control. The existing studies are relatively small and limited in number, suggesting cardamom should be viewed as a complementary approach rather than a primary intervention. More large-scale, long-term human trials are needed to establish its clinical significance compared to established pharmaceutical or well-researched herbal options.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*